In the context of a tumor, high concentrations of adenosine produced by CD73-expressing fibroblasts, tumor-infiltrating immune cells and/or tumor cells [44, 45], may increase CXCL12 expression in fibroblasts themselves through A2BR. This evidence concerns the gene CXCL12 and neoplasm.